RENN Health review

RENN Health for mothers: our verdict

Semaglutide is advertised as low as $149 a month and tirzepatide at $199, and after previously disagreeing with itself the site now quotes the same figures on the homepage and on each drug page. Read both as floors rather than rates. No ceiling is published, no dose ladder appears anywhere, and the three- and six-month bundles carry stack discounts that are never quantified, so nothing on the public pages lets a family work out what treatment costs once the dose settles. The clearest gap is the memberships page, which names tiers and publishes no price for any of them despite the memberships appearing to be how the programs are actually sold. RENN is a California-based virtual weight-loss and performance clinic that also offers NAD+ therapy and delivers medication directly. The compounding pharmacies are never named, and the only coverage statement is that the website may be accessed from all fifty states, which is a claim about the website rather than about where it is licensed to treat. It runs about $149/month — toward the affordable end of what we track.

We weigh RENN Health the way mothers actually have to: not just the real monthly cost, but the real monthly cost once the dose climbs and whether a real clinician stands behind it — the things a generic roundup never gets to.

What RENN Health actually costs

• Compounded semaglutide — Monthly plan, lowest advertised rate: $149/mo
• Compounded tirzepatide — Monthly plan: $199/mo

That sits below the roughly $179 median ongoing price across the providers we track for mothers — a real cost advantage.

The medications RENN Health prescribes

RENN Health prescribes semaglutide and tirzepatide — the pair with the strongest evidence behind them, and having both under one account matters when insulin resistance, familiar from PCOS and gestational diabetes, makes tirzepatide the better fit. These are compounded formulations from a licensed pharmacy — the reason the price stays down — but compounded GLP-1s aren't FDA-approved finished products the way Wegovy and Zepbound are.

Where RENN Health fits — and where it doesn't — for mothers

Worth it if…

• the real monthly cost is a real barrier and you want a low, predictable number.
• you may need to move between semaglutide and tirzepatide as your body and hormones change.

Give it a miss if…

• you specifically want an FDA-approved brand pen with its own pregnancy and lactation labeling.
• you'd rather a prescriber talk through timing around the real monthly cost once the dose climbs — that's what our #1 pick, CoreAge Rx, is built for.

Trust, safety, and oversight

Our confidence is moderate — the core facts check out, but some details (per-state availability, program mechanics) aren't fully public. As with any compounded GLP-1, the most useful thing mothers can do is confirm which licensed pharmacy fills the prescription and what's in the formulation — we explain how we weigh oversight in our Editors' Rating methodology.

A standing caveat for mothers: GLP-1 medications aren't established as safe during pregnancy or breastfeeding, and every label advises against use. Nothing here changes that — plan the timing with your own clinician.

The bottom line

RENN Health is a genuine value play — weigh it on the real monthly cost once the dose climbs and whether a real clinician stands behind it against the alternatives below. For most mothers, CoreAge Rx remains the stronger all-round fit — see why it tops our ranking.